Novavax, Inc. (NASDAQ:NVAX) has a beta value of 1.97 and has seen 13.82 million shares traded in the last trading session. The company, currently valued at $1.83B, closed the last trade at $13.01 per share which meant it lost -$1.39 on the day or -9.65% during that session. The NVAX stock price is -15.3% off its 52-week high price of $15.00 and 72.87% above the 52-week low of $3.53. The 3-month trading volume is 12.77 million shares.
Novavax, Inc. (NASDAQ:NVAX) trade information
Sporting -9.65% in the red in last session, the stock has traded in the green over the last five days, when the NVAX stock price touched $13.01 or saw a rise of 13.27%. Year-to-date, Novavax, Inc. shares have moved 171.04%, while the 5-day performance has seen it change 46.51%. Over the past 30 days, the shares of Novavax, Inc. (NASDAQ:NVAX) have changed 234.45%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Novavax, Inc. (NVAX) estimates and forecasts
Figures show that Novavax, Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 109.84% over the past 6 months, with this year growth rate of 88.72%, compared to 14.60% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 11.55% over the past 5 years. Earnings growth for 2024 is a modest 101.17% while over the next 5 years, the company’s earnings are expected to increase by 37.90%.
NVAX Dividends
Novavax, Inc. is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
